The 100th Anniversary of the Teijin Group Celebrating Teijin Pharma’s History as a Core Part of Teijin
June 17, 2018 marked 100 years since the founding of Teijin. With healthcare as a core pillar of the Teijin Group’s operation, Teijin Pharma have played a key role so far in the history of Teijin. Read on to find out more.
Pharmaceutical Business / Cardiovascular and Metabolic Diseases
Building New Alliances and Realizing the Potential of Our Network Expanding the Range of Treatments Available to Patients of Acromegaly
Teijin Pharma realizes the importance of choice for patients. When it comes to treatments, patients benefit from a range of options to suit their personal circumstances. In the case of Acromegaly, Teijin Pharma saw how they could improve patients’ quality of life through Somatuline subcutaneous injection.
The History of Our Home Oxygen Therapy Enriching the Lives of Patients through Our Community
Home Oxygen Therapy (HOT) was a major part of the forming chapter of the Teijin Pharma story, as explored in Project Story Vol. 6. But the development of Teijin’s first membrane-type oxygen concentrator and its subsequent release in 1982 is only half the story. Teijin’s HOT technology has gone on growing and evolving alongside the business that supports it.
The History of Our Home Oxygen Therapy Building a New Culture of Healthcare through Innovation
Dedicated to pioneering medical solutions, Teijin Pharma began business with the
same commitment to taking on new challenges which they have to this day. The
ability to recognize the needs of the healthcare industry and commit to the right
solutions has defined the company from day one.
How Teijin Pharma Is Changing the Future of Pharmaceutical Manufacturing
Creating Products to Match Medical Needs
In line with their philosophy to Enhance Quality of Life, Teijin Pharma has launched a new 45 mg reduced-size tablet form of their proprietary expectorant drug. Read on to find out how this small modification will greatly change the way patients of respiratory diseases are treated.
SLEEPMATE® Is a Medical Device Designed to Help People Suffering from SAS – Improving Quality of Life for SAS Patients
Sleep Apnea Syndrome (SAS) is a modern disorder that is estimated to affect more than 3 million people in Japan. Learn how Teijin utilized its home healthcare business expertise and insights to develop SLEEPMATE, an innovative device that treats SAS.
Utilizing Teijin Group Synergies to Provide a Wide Range of Treatments
Building a Strong Platform in the Field of Bone and Joint Diseases
Teijin Pharma are always looking ahead. Since they first foresaw the importance of treating osteoporosis in the 1980s, Teijin Pharma have challenged development of everything from simple diagnostic tools to a wide range of treatments in the field of bone and joint diseases.
Pharmaceutical Business / Cardiovascular and Metabolic Diseases
A New Drug Born from R&D
Teijin Pharma has three target categories within the world of healthcare, bone and joint diseases, respiratory diseases and cardiovascular and metabolic diseases. This is the story of a new drug which helped us to grow in the cardiovascular and metabolic diseases’ field, improving quality of life for patients.
We use cookies to help improve your experience on our website. Clink on "Agree" to agree and proceed, or click on "See Details" for more information and settings of cookies.
Special Edition
The 100th Anniversary of the Teijin Group Celebrating Teijin Pharma’s History as a Core Part of Teijin
Pharmaceutical Business / Cardiovascular and Metabolic Diseases
Building New Alliances and Realizing the Potential of Our Network Expanding the Range of Treatments Available to Patients of Acromegaly
Home Healthcare Business / Respiratory Diseases
The History of Our Home Oxygen Therapy Enriching the Lives of Patients through Our Community
Home Healthcare Business / Respiratory Diseases
The History of Our Home Oxygen Therapy Building a New Culture of Healthcare through Innovation
Pharmaceutical Business / Respiratory Diseases
How Teijin Pharma Is Changing the Future of Pharmaceutical Manufacturing Creating Products to Match Medical Needs
Home Healthcare Business / Respiratory Diseases
SLEEPMATE® Is a Medical Device Designed to Help People Suffering from SAS – Improving Quality of Life for SAS Patients
Pharmaceutical Business / Bone and Joint Diseases
Utilizing Teijin Group Synergies to Provide a Wide Range of Treatments Building a Strong Platform in the Field of Bone and Joint Diseases
Home Healthcare Business / Respiratory Diseases
Teijin Pharma’s Response to the Great East Japan Earthquake – Providing Home Healthcare Support in a Disaster
Pharmaceutical Business / Cardiovascular and Metabolic Diseases
A New Drug Born from R&D
